An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial led by National Institutes of Health scientists and their colleagues. According to the World Health Organization, the MERS coronavirus has spread to 27 countries and sickened more than 2,000 people, of whom about 35 percent have died.
The Department of Homeland Security Science and Technology Directorate’s Commercial Aircraft Vulnerability and Mitigation (CAVM) program supports testing and evaluation efforts to assess potential vulnerabilities and evaluate countermeasures that can mitigate the impact of explosives on commercial aircraft. CAVM and partners recently developed a reusable Aircraft Explosive Testing Simulator that facilitates testing for new generation commercial aircraft.
First responders across the nation now have a wireless broadband network to call their own. With all 50 states, two U.S. territories, and Washington, D.C., joining FirstNet, public safety has a new choice for its communications that will help save lives and protect communities.
A new DARPA program called Preventing Emerging Pathogenic Threats (PREEMPT) seeks to support military readiness by going after new viral infectious diseases at the source, animal reservoirs – the species in which a pathogen lives, multiplies, and potentially evolves into a strain that can threaten humans.
The Federal Emergency Management Agency’s Center for Domestic Preparedness announced that, beginning on 11 January 2018, the Center will resume using nerve agents and biologicals in some of its hazardous materials training courses.
The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) and its research and development partners today issued a request for innovators seeking to prototype, test, and transition cutting-edge emergency response technologies. The goal is to put tools with smart city and internet of things capabilities into the hands of first responders by 2020.
At the end of December 2017, WHO prequalified the first conjugate vaccine for typhoid, Bharat Biotech’s Typbar-TCV®. Typhoid conjugate vaccines (TCVs) are innovative products that have longer-lasting immunity than older vaccines, require fewer doses, and can be given to young children through routine childhood immunization programs.
With hospitals more often reaching for antibiotics of last resort to fight infections, the worldwide scientific community has been challenged with developing new antimicrobials to safeguard the population. The Defense Advanced Research Program Agency, or DARPA put out a call for researchers to figure out a process for making at least 1,000 doses to potentially any pathogen within a week of its discovery. An Arizona State University team rose to the challenge.
A pilot project by the Department of Homeland Security Science and Technology Directorate (S&T) resulted in the successful remediation of potential cybersecurity vulnerabilities in mobile applications used by the nation’s public-safety professionals, supporting the creation of an on-going mobile app-testing program.
In mid-November 2017, the U.S. Department of Homeland Security (DHS) Science and Technology Directorate and Defence Research and Development Canada’s Centre for Security Science tested and demonstrated that seamless communication is possible between first responders from both sides of the border during a major emergency.